Dergiler / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 3

Can apelin play a role in the etiology of tinnitus?

Sayfa
769–773
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Further clinicalstudies on the effects of the apelin/APJ (apelin junction receptor) system and the effects of antioxidants in patients with inflammatorydiseases are required.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Tinnitus is seen in 15% of the general population; in 1%–6% of this number, the quality of life is seriously affectedby this chronic condition.
📊
Temel Bulgular & Veri:We recorded the levels of plasma apelin-13 and biochemical parameters.Results: The mean apelin level of the control group was higher than that of the patient group (P = 0.002).
💡
Sonuç & Katkı:Further clinicalstudies on the effects of the apelin/APJ (apelin junction receptor) system and the effects of antioxidants in patients with inflammatorydiseases are required.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Tinnitus is seen in 15% of the general population; in 1%–6% of this number, the quality of life is seriously affectedby this chronic condition. Chemical, oxidative, and emotional stressors are important in terms of the clinical course of tinnitus. Apelinis an endogenous peptide which is an oxidative stress mediator. It has been shown that the apelin/APJ (apelin junction receptor) systemplays various roles in the physiology and pathophysiology of many organs. However, the role of the apelin/APJ system as an oxidativestress mediator in tinnitus is unknown. We investigated the level of apelin in patients with normal hearing and bilateral tinnitus.Materials and methods: We enrolled patients diagnosed with bilateral idiopathic tinnitus. Tinnitus severity was determined using thetinnitus handicap inventory (THI). We recorded the levels of plasma apelin-13 and biochemical parameters.Results: The mean apelin level of the control group was higher than that of the patient group (P = 0.002). A significant negativecorrelation was evident between the apelin level and the THI (r = –0.460, P = 0.003). The triglyceride (TG) level was significantly higherin the patient group than in the control group (P < 0.001).Conclusions: In our study, we found a negative correlation between apelin and tinnitus severity. Thus, apelin may play a role in thepathophysiology of idiopathic tinnitus, and may be prescribed during follow-up to reduce oxidative stress in the future. Further clinicalstudies on the effects of the apelin/APJ (apelin junction receptor) system and the effects of antioxidants in patients with inflammatorydiseases are required.

🔖

Bu Makaleye Atıf Yap

GÜR, N., RENDA, L., ENSARİ, N., SELÇUK, Ö. T., ÇEKİN, Y., ÖZTÜRK, M. T., GÜR, Ö. E., YILMAZ, M. D. (2022). Can apelin play a role in the etiology of tinnitus?. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 3, 769–773. https://ajindex.com/articles/610095

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am 2003; 36: 239-248
  2. Sindhusake D, Golding M, Wigney D, Newall P, Jakobsen K, Mitchell P. Factors predicting severity of tinnitus: a populationbased assessment. J Am Acad Audiol 2004; 15: 269-280
  3. Gilles A, Camp G V, Heyning P V, Fransen E. A pilot genomewide association study identifies potential metabolic pathways involved in tinnitus. Front Neurosci 2017; 11: 71. doi: 10.3389/ fnins.2017.00071
  4. Alpini D, Cesarani A. Tinnitus as an alarm bell: stress reaction tinnitus model. ORL J Otorhinolaryngol Relat Spec 2006; 68: 31-36
  5. O’Down BF, Heiber M, Chan A, Heng HHQ HH, Tsui LC, Kennedy JL, Shi XM, Petronis A. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome-11. Gene 1993; 136: 355-360
  6. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Bioph Res Co 1998; 251: 471-476
  7. Lu He, Jin Xu, Linxi Chen, Lanfang Li. Apelin/APJ signaling in hypoxia-related diseases. Clinica Chimica Acta 2015; 451, 191-198
  8. Zhou Y, Wang Y, and Qiao S. Apelin: a potential marker of coronary artery stenosis and atherosclerotic plaque stability in ACS patients. Int Heart J 2014; 55: 204-212
  9. Foldes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt A, Mayranpaa M, Sarman B, Seres L, Skoumal R et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Bioph Res Co 2003; 308: 480-485
  10. Japp AG, Cruden NL, Amer DAB, Li VKY, Goudie EB, Johnston NR, Sharma S, Neilson I, Webb DJ, Megson IL et al. Vascular effects of apelin in vivo in man. J Am Coll Cardiol 2008; 52: 908-913
  11. Kawamata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O, Fujino M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538: 162-171
  12. Zhong JC, Zhang ZZ, Wang W, McKinnie SM, Vederas JC, Oudit GY. Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases. Biochim Biophys Acta 2017 Aug; 1863: 1942-1950
  13. Zhou Q, Cao J, Chen L. Apelin/APJ system: a novel therapeutic target for oxidative stress-related inflammatory diseases (review). Int J Mol Med 2016; 37: 1159-1169
  14. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K, Fujimiya M. The no